Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Noribogainalog

From Wikipedia, the free encyclopedia

Pharmaceutical compound
Noribogainalog
Clinical data
Other namesNor-IBG; 9-Hydroxyibogaminalog
Identifiers
  • 3-methyl-2,4,5,6-tetrahydro-1H-azepino[4,5-b]indol-9-ol
CAS Number
PubChemCID
ChemSpider
Chemical and physical data
FormulaC13H16N2O
Molar mass216.284 g·mol−1
3D model (JSmol)
  • CN1CCC2=C(CC1)NC3=C2C=C(C=C3)O
  • InChI=1S/C13H16N2O/c1-15-6-4-10-11-8-9(16)2-3-12(11)14-13(10)5-7-15/h2-3,8,14,16H,4-7H2,1H3
  • Key:OOROJSRWMMKEQK-UHFFFAOYSA-N

Noribogainalog (nor-IBG), also known as9-hydroxyibogaminalog, is adrug of theibogalog family related tonoribogaine.[1][2] It is a simplifiedanalogue of noribogaine.[1][2]

Pharmacology

[edit]

The drug acts as apotentserotonin5-HT2A receptorpartial agonist (EC50Tooltip half-maximal effective concentration ≈ 90 nM;EmaxTooltip maximal efficacy = 35%).[2] It also has activity as adopamine transporter (DAT)chaperone.[3] Noribogainalog does not affectlocomotor activity, does not produce thehead-twitch response, and does not affect various other physiological and behavioral measures.[2] However, it does produceanalgesic effects that can be diminished by the serotonin 5-HT2A receptorantagonistketanserin.[2] The drug shows relatively low expectedblood–brain barrierpermeability.[2]

History

[edit]

Noribogainalog was first described in thescientific literature byDavid E. Olson and colleagues by 2021.[1]

See also

[edit]

References

[edit]
  1. ^abcCameron LP, Tombari RJ, Lu J, Pell AJ, Hurley ZQ, Ehinger Y, et al. (January 2021)."A non-hallucinogenic psychedelic analogue with therapeutic potential".Nature.589 (7842):474–479.Bibcode:2021Natur.589..474C.doi:10.1038/s41586-020-3008-z.PMC 7874389.PMID 33299186.
  2. ^abcdefArias HR, Micheli L, Jensen AA, Galant S, Vandermoere F, Venturi D, et al. (March 2025). "Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors".Biomedicine & Pharmacotherapy.184 117887.doi:10.1016/j.biopha.2025.117887.hdl:2158/1423286.PMID 39938347.
  3. ^Sutton C, Williams EQ, Homsi H, Beerepoot P, Nazari R, Han D, et al. (2022)."Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones".Frontiers in Cellular Neuroscience.16 832536.doi:10.3389/fncel.2022.832536.PMC 9124866.PMID 35614973.

External links

[edit]


5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=Noribogainalog&oldid=1317787852"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp